Access Patient Resources

Understanding the medical and pharmaceutical landscape is an essential – and oftentimes, first – step for any patient and their loved ones after a diagnosis. We’ve pulled together a wide range of informative resources on diseases, research, treatments, programs, coverage, and more to help patients at every step of their journey. Explore them below. 

Report

Chart Pack: Biopharmaceuticals in Perspective, Summer 2019

This chart pack provides facts and figures about prescription medicines and their role in the health care system.

Blog Post

Keep the Six Protected Classes, Protected

Blog Post

New whitepaper identifies reasons why ICER's cost-effectiveness analyses are not useful for payers

Blog Post

What if a couple of small fixes could protect seniors in the donut hole and save them money on out-of-pocket costs?

Video

Together - CAR-T

Justin's story of resilience and hope inspire researchers like Boris to #GOBOLDLY and never stop searching for a cure to cancer.

Blog Post

How much do you know about Medicare Part B?

Blog Post

Diversity of thought fuels next generation of breakthroughs

Blog Post

Guest post: Ensuring communities have a seat at the table: The importance of diversity in clinical trials

Blog Post

Improve women's health by treating the disease, not the pain

Blog Post

PPA celebrates 13 years of helping patients access their medicines

Blog Post

Improving care quality by engaging patients in shared decision making

Blog Post

Ask About Adherence: New study demonstrates how adherence programs can improve health outcomes for patients with cardiovascular disease

Fact Sheet

Biopharmaceutical Companies’ Personalized Medicine Research Yields Innovative Treatments for Patients

The last five years have been characterized by increased momentum in personalized medicine.

Report

Follow the Dollar Report

This paper provides an explanation of the financial flows that occur as brand medicine move through the supply chain.

Report

Follow the Dollar Executive Summary

Drug pricing is a complex and often confusing issue, shaped by a payment system that involves numerous stakeholders.

Graphic

Follow the Dollar: Flow of Payment for a $400 Insulin

Scott takes insulin for his type 2 diabetes and has a health plan with a high deductible.

Graphic

Follow the Dollar: Janet

Janet is enrolled in a commercial health insurance plan and has a $40.00 copay for her blood pressure medicine.

Blog Post

340B Spotlight: ICYMI – 340B hearing, new reports highlight growing need for program reform

Blog Post

VIDEO: Myvideopays CEO discusses industry response to opioid crisis on Mornings with Maria

Video

Together - ALS

Pat’s words and optimism are what inspire researchers like Pablo to #GoBoldly every day and never stop searching for a cure to end ALS.

Report

Medicines in Development for HIV 2017 Report

America’s biopharmaceutical research companies are developing 52 medicines and vaccines for HIV.

Report

List of Medicines in Development for HIV

More than 50 medicines and vaccines are in development for HIV/AIDS infection treatment and prevention.

Blog Post

A critical opportunity to prevent prescription drug abuse

Fact Sheet

PREA and BPCA: Spurring Pediatric Drug Development

PREA and BPCA work together to foster pediatric drug development.

Blog Post

12 years of the Partnership of Prescription Assistance

Blog Post

Medicare Monday: A discussion on affordability and access to medicines

Blog Post

17 years (and more) of medical discoveries

Blog Post

How do multiple sclerosis patients define value?

Blog Post

ICYMI: New era of medicine initiative kicks off in Boston

Blog Post

Biopharmaceutical industry’s success reducing disparities for African Americans

Video

America’s biopharmaceutical industry is central to diverse R&D ecosystem

Dr. Tim Garnett, CMO of Eli Lilly and Company, emphasizes that creating lifesaving medicines is the focus of the biopharmaceutical industry.

Graphic

Actual Versus Projected Death Rates for HIV/AIDS in the U.S.

The introduction of HAART treatments caused a significant drop in the HIV/AIDS death rate.

Video

Clinical Trials - What You Need to Know

Clinical trials are central to the work of biopharmaceutical researchers - they advance the science of bringing new medicines to patients.

Video

Improve Access to Important Clinical Information

Learn how insurers use a range of techniques that may interfere with a doctor’s prescribed course of treatment and impact patient care.

Fact Sheet

Patient-Focused Drug Development

Incorporating the patient’s voice in the development and the U.S. Food and Drug Administration’s (FDA) evaluation of new medicines.

Graphic

4 Reasons Why Importing Drugs is Bad for Patients

This infographic details four reasons why importing drugs is bad for patients, especially regarding safety.

Graphic

How patients with dyslipidemia save with Medicare Part D

Patients with dyslipidemia save with Medicare Part D. This graphic shows how.

Graphic

How patients with heart failure save with Medicare Part D

See how patients with congestive heart failure save with Medicare Part D.

Graphic

High Cholesterol Patient Profile - Sheryl

Sheryl has been able to get her high cholesterol under control through lifestyle changes like diet and exercise.

Graphic

Patient Profile: Bill

Every 40 seconds, an American adult dies from a heart attack, stroke, or vascular disease, equating to nearly 800,000 deaths per year.

Graphic

How patients with hypertension save with Medicare Part D

Adherent seniors’ net savings were approximately $5,824 per year compared to non-adherent beneficiaries.

Graphic

Falling Death Rates for HIV/AIDS Patients

This data visualization provides a look at the actual vs projected death rates for HIV/AIDs in the United States.

Codes & Guidelines

Principles on Interactions with Patient Organizations

Biopharmaceutical companies share with patient organizations a commitment to patients and a mission to discover cures and fight disease.

www.farm-pump-ua.com

www.avtomaticheskij-poliv.kiev.ua

https://medicaments-24.net